ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "inflammasome activation"

  • Abstract Number: 2437 • 2019 ACR/ARP Annual Meeting

    Autoantibodies from Sjögren’s Syndrome Enhance NLRP3 Inflammasome Activation and IL-18 Production in Human Salivary Gland Cell Line A-253

    Cheng-Han Wu1, Ko Jen Li 2, Chia-Li Yu 3 and Song-Chou Hsieh 3, 1Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan, Taipei, Taiwan (Republic of China), 2National Taiwan University Hospital, Taipei, Taiwan (Republic of China), 3Division of Immunology,Rheumatology and Allergy, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan, Taipei, Taiwan (Republic of China)

    Background/Purpose: Primary Sjögren's syndrome (SS) is a chronic autoimmune epithelitis characterized by the presence of autoantibodies against SS-related antigen A (SSA) and lymphocytic infiltration of…
  • Abstract Number: 2250 • 2018 ACR/ARHP Annual Meeting

    Mitigation of Inflammation Induced By Monosodium Urate Crystals in Mice By Treatment with Svp-Rapamycin

    Pallavi Kolte, Robert LaMothe, Joseph Ferrari, Sheldon Leung, Wesley DeHaan Ph.D., Earl Sands and Takashi Kei Kishimoto, Selecta Biosciences, Watertown, MA

    Background/Purpose:  Initiation of urate-lowering therapies is typically associated with an increase in gout flares due to mobilization of pro-inflammatory urate crystals.  SEL-212 is a novel…
  • Abstract Number: 2067 • 2018 ACR/ARHP Annual Meeting

    Dysbiosis-Dependent Inflammasomes Activation Drives Innate Immune Responses in Ankylosing Spondylitis Patients

    Francesco Ciccia1, Giuliana Guggino1, Aroldo Rizzo2, Stefania Raimondo3, Simon Milling4 and Riccardo Alessandro3, 1Rheumatology Unit, University of Palermo, Palermo, Italy, 2Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy, 3University of Palermo, Palermo, Italy, 4University of Glasgow, Glasgow, United Kingdom

    Background/Purpose: A growing body of evidences indicate that the aberrant activation of innate immune systems, occurring in genetically predisposed patients, drives inflammatory processes in Ankylosing…
  • Abstract Number: 2245 • 2018 ACR/ARHP Annual Meeting

    Lubricin/Proteoglycan 4 (PRG4) Inhibits NLRP3 Inflammasome Assembly in Monosodium Urate (MSU)-Crystal Induced Arthritis.

    Anthony M. Reginato1, Changqi Sun2, Elsaid A. Khaled3, Tannin A. Schmidt4, Olin D. Liang5 and Gregory D Jay6, 1Division of Rheumatology, Rhode Island Hospital, Providence, RI, 2Division of Rheumatology, Rhode Island Hospital, Providence, MA, 3Department of Biomedical and Phramaceutical Science, Chapman University School of Pharmacy, Irvine, CA, 4Biomedical Engineering, University of Connecticut Health Center, Framington, CT, 5Division of Hematology/Oncology, Rhode Island Hospital, Providence, RI, 6Department of Emergency Medicine, Rhode Island Hospital, Providence, RI

    Background/Purpose: Lubricin/proteoglycan-4 (PRG4) is a mucinous glycoprotein secreted by synovial fibroblast and superficial zone chondrocytes. PRG4 has a multifaceted homeostatic role in the joint including…
  • Abstract Number: 77 • 2017 ACR/ARHP Annual Meeting

    Platelets Induce IL-1b Production in Human Monocytes through NLRP3 Inflammasome Activation

    Shota Nakano1, Hiroki Mitoma1, Shotaro Kawano1, Shoichiro Inokuchi2, Masahiro Ayano1, Yasutaka Kimoto3, Mitsuteru Akahoshi1, Yojiro Arinobu1, Koichi Akashi1, Takahiko Horiuchi4 and Hiroaki Niro5, 1Department of Medicine and Biosystemic Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, 2Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan, 3Department of Internal Medicine, Kyushu University Beppu Hospital, Oita, Japan, 4Department of Internal Medicine, Kyushu University Beppu Hospital, Beppu, Japan, 5Department of Medical Education, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan

    Background/Purpose: Recent studies have revealed that platelets play pivotal roles in inflammation in addition to hemostasis. The thrombus induces subsequent local inflammation and reversely the…
  • Abstract Number: 557 • 2017 ACR/ARHP Annual Meeting

    Enhanced Expression of NLRP3 Inflammasome-Related Inflammation in Peripheral Blood Mononuclear Cells in Sjögren’s Syndrome

    Seong-Kyu Kim1, Jung-Yoon Choe2, Sung-Hoon Park3 and Hwajeong Lee2, 1Rheumatology, Catholic University of Daegu School of Medicine, Daegu, Korea, Republic of (South), 2Catholic University of Daegu School of Medicine, Daegu, Korea, Republic of (South), 3Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea, Republic of (South)

    Background/Purpose: Sjögren's syndrome is a systemic autoimmune disease characterized by lymphocyte infiltration and subsequent dysfunction of exocrine glands, finally leading to dryness in the exocrine…
  • Abstract Number: 938 • 2017 ACR/ARHP Annual Meeting

    A Germline Macrophage Activation Syndrome-Associated Nlrc4 Mutation Causes Chronic, Systemic, Non-Hematopoietic IL-18 Elevation and Intestinal MHC-II Upregulation

    Eric Weiss1, Corinne Schneider2 and Scott Canna3, 1RK Mellon Institute, Children’s Hospital of Pittsburgh, Pittsburgh, PA, 2Pediatrics, Children's Hospital Pittsburgh, Pittsburgh, PA, 3NIAMS, National Institutes of Health, Bethesda, MD

    Background/Purpose: Patients prone to the development of Macrophage Activation Syndrome (MAS) can have extreme and often chronic elevation in the pro-inflammatory cytokine interleukin-18 (IL-18). In…
  • Abstract Number: 1445 • 2017 ACR/ARHP Annual Meeting

    Effect of Methotrexate (MTX), and MTX Plus Colchicine (CCH) on the Expression and Activity of NLRP3 Inflammasome in Patients with Early Rheumatoid Arthritis (RA)

    Dolores Ramos-Bello1, Crisol Alvarez-Quiroga2, Georgina Aguilera Barragán-Pickens3, Angel Javier Pedro Martínez3, Tania Adriana Luna-Zúñiga3, Georgina Martínez-Flores3, Eduardo Saul Acevedo-Castañeda4, Homero López-Ferretis3, Enrique Cuevas-Orta3, Eva Santillan-Guerrero3, Ricardo Moreno-Valdez3, Martín Saldaña-Baarnard3, Marco Ulises Martinez-Martinez5, David Herrera Van Oostdam6, Roberto González-Amaro7 and Carlos Abud-Mendoza8, 1Reumatología, Unidad Regional de Reumatologia y Osteoporosis Hospital Central "Dr. Ignacio Morones Prieto" y Facultad de Medicina de la UASLP, San Luis Potosi, Mexico, 2División de Medicina Molecular y Traslacional, Centro de Investigación en Ciencias de la Salud y Biomedicina, UASLP, San Luis Potosí, Mexico, 3Unidad Regional de Reumatologia y Osteoporosis Hospital Central "Dr. Ignacio Morones Prieto" y Facultad de Medicina de la UASLP, San Luis Potosí, Mexico, 4Medicina Interna, Unidad Regional de Reumatologia y Osteoporosis Hospital Central "Dr. Ignacio Morones Prieto" y Facultad de Medicina de la UASLP, San Luis Potosí, Mexico, 5Unidad de Investigaciones Reumatológicas, Faculty of Medicine, Universidad Autónoma de San Luis Potosí and Hospital Central, San Luis Potosí, Mexico, 6Unidad de Investigaciones Reumatológicas, Hospital Central & Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, Mexico, 7Inmunología, Facultad de Medicina de la UASLP, San Luis Potosí, Mexico, 8Unidad de Investigaciones Reumatológicas y Osteoporosis, Faculty of Medicine, Universidad Autónoma de San Luis Potosí and Hospital Central, San Luis Potosí, Mexico

    Background/Purpose: NLRP3 inflammasome is an intracellular protein complex involved in the production of pro-inflammatory cytokines as IL-1β and IL-18, which has been reported to have…
  • Abstract Number: 2334 • 2017 ACR/ARHP Annual Meeting

    Hypermethylation of NLRP3 Promoter Region Could be Responsible for Decreased Gene Expression, Inflammasome Malfunction and Gut Dysbiosis in Juvenile Spondyloarthritis Patients

    Lovro Lamot1,2, Kristina Gotovac Jercic3, Antonela Blazekovic3, Mirta Lamot4, Mandica Vidovic4, Fran Borovecki3 and Miroslav Harjacek3,4, 1Department of Pediatrics, University of Zagreb School of Medicine, Zagreb, Croatia, 2Department of Pediatrics, Division of Clinical Immunology and Rheumatology, Clinical Hospital Center Sestre Milosrdnice, Zagreb, Croatia, 3University of Zagreb School of Medicine, Zagreb, Croatia, 4Clinical Hospital Center Sestre Milosrdnice, Zagreb, Croatia

    Background/Purpose:  Juvenile spondyloarthritis (jSpA) is a complex disease with both genetic and environmental factors contributing to the etiology. Recently obtained gene signatures in jSpA patients…
  • Abstract Number: 2771 • 2017 ACR/ARHP Annual Meeting

    NOMID-Associated Complications in Mice Are Prevented By CDD-450, a Small Molecule Inhibitor of the Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 (MK2) Pathway

    Gabriel Mbalaviele1, Chun Wang1, Susan Hockerman2, Jon Jacobsen2, Jeff Hirsch2, Steve Mnich2, Heidi Hope2, Matt Saabye2, Hal Hoffman3 and Joseph Monahan2, 1Medicine, Washington University School of Medicine,, St. Louis, MO, 2Confluence Life Sciences, Inc, St. Louis, MO, 3University of California, San Diego, San Diego, CA

    Background/Purpose: NLRP3-activating mutations cause cryopyrinopathies of which NOMID is the most severe phenotype. NLRP3 assembles a protein complex, responsible for the maturation of IL-1β and…
  • Abstract Number: 2772 • 2017 ACR/ARHP Annual Meeting

    Unbound IL-18 Distinguishes Human Macrophage Activation Syndrome from Familial Hemophagocytic Lymphohistiocytosis and Affects Innate Versus Adaptive Murine Lymphocytes Differently

    Paul Tsoukas1, Eric Weiss2, Dirk Holzinger3, Charlotte Girard4, Dirk Foell5, Alexei A. Grom6, Sandra Ammann7, Stephan Ehl7, Eduardo Schiffrin8, Adriana Almeida de Jesus9, Raphaela Goldbach-Mansky9, Cem Gabay10 and Scott Canna11, 1Pediatric Rheumatology, Children’s Hospital of Pittsburgh, Pittsburgh, PA, 2RK Mellon Institute, Children’s Hospital of Pittsburgh, Pittsburgh, PA, 3Department of Pediatric Rheumatology and Immunology, University of Muenster, Muenster, Germany, 4Division of Rheumatology, Department of Internal Medicine Specialties, University Hospital of Geneva, Geneva, Switzerland, 5University of Muenster, Muenster, Germany, 6Pediatric Rheumatology, Cincinnati Children’s Hospital, Cincinnati, OH, 7Center for Chronic Immunodeficiency, Faculty of Medicine, University of Freiburg, Freiburg, Germany, 8AB2 Bio, Lausanne, Switzerland, 9Translational Autoinflammatory Disease Studies (TADS), Laboratory of Clinical Investigation and Microbiology (LCIM), NIAID/NIH, Bethesda, MD, 10SCQM, Geneva, Switzerland, Geneva, Switzerland, 11Richard King Mellon Foundation Institute for Pediatric Research, Children's Hospital of Pittsburgh, Pittsburrgh, PA

    Background/Purpose: Persistently and extremely elevated serum IL-18 has been associated with Macrophage Activation Syndrome (MAS). Chronic IL-18 is hypothesized to contribute to excessive interferon (IFN)-g…
  • Abstract Number: 1007 • 2016 ACR/ARHP Annual Meeting

    Interferon Regulatory Factor 1 Is the Key Driver of Inflammasome Activity in Systemic Lupus Erythematosus

    Jianhua Liu1 and J. Michelle Kahlenberg2, 1Internal Medicine, Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2Internal Medicine, Division of Rheumatology, Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI

    Background/Purpose: The inflammasome complex has recently emerged as a driver of organ damage in systemic lupus erythematosus (SLE). This complex, via its enzymatic subunit caspase-1,…
  • Abstract Number: 1963 • 2016 ACR/ARHP Annual Meeting

    Thrombospondin-1 Is Elevated in the Plasma of Patients with Antiphospholipid Syndrome and Is Correlated with Free Active TGF-b1 Levels, IL-1b and IL-17A

    Markos Patsouras, Athanasios G. Tzioufas and Panayiotis G Vlachoyiannopoulos, School of Medicine, Pathophysiology Department, National and Kapodistrian University of Athens, Athens, Greece

    Background/Purpose: Antiphospholipid syndrome (APS) is an acquired thombophillia characterized by recurrent thromboembolism and pregnancy morbidity. Thrombospondin (TSP-1) is a matricellular glycoprotein secreted by platelets upon…
  • Abstract Number: 1985 • 2016 ACR/ARHP Annual Meeting

    IL-18 Elevation in Macrophage Activation Syndrome: Human Evidence for a Chronic Set-Point and Murine Evidence for a Non-Hematopoietic Source

    Zeshan Tariq1, Eric Weiss2, Wendy Goodspeed3, Raphaela Goldbach-Mansky4 and Scott Canna2, 1Autoinflammatory Pathogenesis Unit, NIAMS/NIH, Bethesd, MD, 2Autoinflammatory Pathogenesis Unit, NIAMS/NIH, Bethesda, MD, 3Office of the Clinical Director, NIAMS/NIH, Bethesda, MD, 4Translational Autoinflammatory Disease Studies, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD

    Background/Purpose: Macrophage Activation Syndrome (MAS) is a life-threatening sepsis-like condition complicating many systemic JIA (sJIA) and Adult-Onset Stills Disease (AOSD) patients. We recently identified that…
  • Abstract Number: 2257 • 2016 ACR/ARHP Annual Meeting

    Regulation of Mitochondrial Proton Gradient Is Critical for NLRP3 Inflammasome Activation

    Jehad H. Edwan, Raphaela Goldbach-Mansky and Robert A. Colbert, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD

    Background/Purpose:  Self-activating mutations in NLRP3 cause a spectrum of autoinflammatory diseases known as cryopyrin-associated periodic syndromes (CAPS). NLRP3 is a key component of a multiprotein…
  • 1
  • 2
  • 3
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology